Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 May;51(4):902-904.
doi: 10.1007/s11239-021-02435-1. Epub 2021 Apr 7.

Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority population

Paul A Gurbel  1 , Kevin P Bliden  2 , Amit Rout  2 , Nicole Rapista  2 , Naval Walia  2 , Rahul Chaudhary  3 , Gordon Ens  4 , Malina Traianova  5 , Jaime S Barnes  6 , Udaya S Tantry  2
Affiliations
Observational Study

Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority population

Paul A Gurbel et al. J Thromb Thrombolysis. 2021 May.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
a Anticoagulant response indicated by the change in reaction time by thromboelastography in patients with COVID-19. R reaction time, CK-R reaction time with kaolin channel, CKH-R reaction time in kaolin plus heparinase channel. *p < 0.004 as compared to enoxaparin prophylaxis. +p < 0.05 as compared to enoxaparin prophylaxis. b Urinary 11-dehydro thromboxane B2 in COVID-19 positive and negative patients with and without Aspirin. TI thromboinflammation, TR therapeutic response [6]
See this image and copyright information in PMC

References

    1. Chaudhary R, Kreutz RP, Bliden KP, Tantry US, Gurbel PA. Personalizing antithrombotic therapy in COVID-19: role of thromboelastography and thromboelastometry. Thromb Haemost. 2020;120:1594–1596. doi: 10.1055/s-0040-1714217. - DOI - PubMed
    1. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18:1094–1099. doi: 10.1111/jth.14817. - DOI - PMC - PubMed
    1. Gurbel PA, Bliden KP, Schrör K. Can an old ally defeat a new enemy? Circulation. 2020;142:315–317. doi: 10.1161/CIRCULATIONAHA.120.047830. - DOI - PMC - PubMed
    1. Gurbel PA, Bliden KP, Tantry US, Monroe AL, Muresan AA, Brunner NE, Lopez-Espina CG, Delmenico PR, Cohen E, Raviv G, Haugen DL, Ereth MH. First report of the point-of-care TEG: a technical validation study of the TEG-6S system. Platelets. 2016;27:642–649. doi: 10.3109/09537104.2016.1153617. - DOI - PubMed
    1. Van PY, Cho SD, Underwood SJ, Morris MS, Watters JM, Schreiber MA. Thrombelastography versus AntiFactor Xa levels in the assessment of prophylactic-dose enoxaparin in critically ill patients. J Trauma. 2009;66:1509. - PubMed

Publication types

MeSH terms

LinkOut - more resources